EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Plant-Derived Nanovesicles in Cancer Therapy: Product Identity, Evidence Appraisal, and Formulation Design

Fuzhuo Wang, Yang Sun, Yi Chen, Jiashuang Xu, Ye Huang, Guangpeng He

International Journal of Nanomedicine · 2026-11 · Volume 21 · 1-18

DOI: 10.2147/ijn.s654409 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026-11. Verfasst von Fuzhuo Wang und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Wang, F., Sun, Y., Chen, Y., Xu, J., Huang, Y., & He, G. (2026). Plant-Derived Nanovesicles in Cancer Therapy: Product Identity, Evidence Appraisal, and Formulation Design. International Journal of Nanomedicine, Volume 21, 1-18. https://doi.org/10.2147/ijn.s654409

Vancouver

Wang F, Sun Y, Chen Y, Xu J, Huang Y, He G. Plant-Derived Nanovesicles in Cancer Therapy: Product Identity, Evidence Appraisal, and Formulation Design. International Journal of Nanomedicine. 2026;Volume 21:1-18. doi:10.2147/ijn.s654409

BibTeX
@article{Wang2026,
  author = {Wang, Fuzhuo and Sun, Yang and Chen, Yi and Xu, Jiashuang and Huang, Ye and He, Guangpeng},
  title = {Plant-Derived Nanovesicles in Cancer Therapy: Product Identity, Evidence Appraisal, and Formulation Design},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  volume = {Volume 21},
  pages = {1--18},
  doi = {10.2147/ijn.s654409}
}
Kostenlos starten →